TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015 November 26, 2014
TCL Archive North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups July 10, 1981
TCL Archive In Brief: McIntyre To Replace Frei As Group Chairman Abeloff, Murphy Nominated For ASCO Presidency January 26, 1990
